Determination of Advanced Oxidation Protein Products, E3 SUMO-Protein Ligase NSE2[NSMCE2], as a Marker to Predict Child Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is a cancer of the blood and bone marrow (spongy tissue in the center of bone). In ALL, too many bone marrow stem cells develop into a type of white blood cell called lymphocytes. These abnormal lymphocytes are not able to fight infection very well. The aim of this...
Saved in:
| Main Author: | Baghdad Science Journal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Baghdad, College of Science for Women
2014-03-01
|
| Series: | مجلة بغداد للعلوم |
| Subjects: | |
| Online Access: | http://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/1543 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of Some Biochemical Parameters in Iraqi Children with Acute Lymphoblastic Leukemia
by: Baghdad Science Journal
Published: (2015-06-01) -
Does distance to the hospital affect the course of treatment and follow-up for children with Acute Lymphoblastic Leukemia?
by: Cecilie Bjerregaard Brix, et al.
Published: (2025-02-01) -
Correlation of Baseline Clinical Characteristics as Risk Factors for Pneumonia in Children with Acute Lymphoblastic Leukemia (ALL)
by: Prachi Singh, et al.
Published: (2025-03-01) -
Revumenib as A New Therapeutic Intervention for Relapsed or Refractory KMT2A-Rearranged Acute Lymphoblastic Leukemia
by: Khushbakht Baloch, et al.
Published: (2025-04-01) -
Is the vIL-10 Protein from Cytomegalovirus Associated with the Potential Development of Acute Lymphoblastic Leukemia?
by: Ruvalcaba-Hernández Pamela, et al.
Published: (2025-03-01)